Loading patent…
AssigneeNutriScience Innovations LLC
InventorMichael Lelah
Estimating the term…
The present disclosure relates to compositions and methods for helping to manage the lingering symptoms and effects of COVID-19 after recovery. Specifically, the present disclosure relates to sustained release dietary and nutritional supplement compositions and methods to provide ongoing support and symptom management for individuals exposed to SARS-CoV-2 who contacted COVID-19 and later recovered but continue to experience after-effects or lingering symptoms. Specifically, the composition is based on a sustained release ashwagandha extract, alone in a therapeutically effective amount, or in combination with other ingredients.
A sustained release dietary supplement composition comprising active ingredients formulated in a therapeutic effective amount to manage lingering symptoms in patients recovering from COVID-19 due to SARS-CoV-2 virus.
A sustained release tablet or capsule comprising an ashwagandha extract formulated in a therapeutic effective amount to manage lingering symptoms in patients recovering from COVID-19 due to the SARS-CoV-2 virus.
A method for supporting symptom management, including after-effects and/or lingering symptoms of COVID-19, the method comprising the steps of administering to the patient in need thereof a therapeutically effective amount of a sustained release nutritional supplement comprising ashwagandha and compositions containing ashwagandha.
Dependencies are inferred from the claim text.